Nippon Kayaku has been undertaking contract manufacturing business as a part of its pharmaceutical business. Making use of the vast amount of technology that we have acquired for the production of high-potency active ingredients, we have been undertaking contract manufacturing of active pharmaceutical ingredients(API).

Nippon Kayaku's strength lies in the fact that we have already integrated the original synthesis technologies with bioscience technologies. Since the production of anti-cancer and other drugs that contain high-potency active ingredients, in particular, requires sophisticated technologies and vast reserves of knowledge and experiences, our integrated technologies can exercise their power. The production of anti-cancer drugs obviously requires thorough good manufacturing practices (GMP), which are the standards related to manufacturing control and quality control of pharmaceuticals. Nippon Kayaku has been pursuing its business by considering these standards to be the most important factors in safety management.

Because anti-cancer drugs are more potent than other pharmaceuticals and require special measures for hazard protection, the production process must be controlled very strictly.

Therefore, Nippon Kayaku has installed multipurpose production equipment for chemically hazardous drugs, while making efforts to construct a system to perfectly contain these drugs. Nippon Kayaku has been producing pharmaceuticals by considering environment and safety management by introducing global standards of GMPs, such as cGMP and EU-GMP.